Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imlifidase in Highly Sensitized Children Receiving a Kidney Transplant
NCT05753930Phase 2Recruiting
- Sponsor
- Hansa Biopharma
- Start
- Jun 2023
- Primary completion
- Feb 2027
- Countries
- 5
01
Overview
A Phase 2 trial of imlifidase in end stage renal disease (ESRD), sponsored by Hansa Biopharma. Started Jun 2023; status: recruiting.
02
Drugs
imlifidase
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT05753930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05753930.